Fusing biology with the bionic ear
E&T
JULY 7, 2023
These cells are like ‘keys on a piano’ and range from low to high frequency, explains Dr Robert Gay, director of pharmaceutical approaches at Cochlear, a Sydney-based manufacturer of the device. The idea of using optical stimulation to overcome the bottleneck of poor spectral selectivity could be transforming.
Let's personalize your content